The AI Trillion Dollar Question
Written by Michael Lebowitz and Lance Roberts | Oct 10, 2025 | Daily Market CommentaryAccording to The Wall Street Journal, on an inflation-adjusted basis, technology companies have spent more…
> Read MoreAccording to The Wall Street Journal, on an inflation-adjusted basis, technology companies have spent more…
> Read MoreThe graph below, courtesy of the St. Louis Fed, charts the amount of money in…
> Read MoreAs we led in yesterday’s Commentary, AMD rose 25% on the news that OpenAI would…
> Read MoreAdvanced Micro Devices (AMD) stock opened up by nearly 35% on Monday morning, following reports…
> Read MoreThe following discussion is courtesy of Paul Mortimer Lee, as provided by Edward Albert. Paul…
> Read More🔎 At a Glance Government Shutdown – A Repeat Of The Past Bubble In AI:…
> Read MoreEli Lilly and other US-based drug makers have led the market over the last few…
> Read MoreIn Monday’s Commentary, we alerted readers that the dollar could be setting up for a reversal…
> Read MoreIn a bold and unusual pivot, a traditional Japanese manufacturer of Kimonos is transitioning to…
> Read MoreRebalancing the Crypto model for a second time in a week after a 5% gain in the model yesterday unbalanced the model. Selling 50% of BKKT and increasing IBIT and ETHA to 20% of the portfolio.
> Read MoreIf Congress can’t come to a budget resolution in the next 24 hours, the government…
> Read MoreWe rebalanced all core models today to target portfolio weights.
> Read MoreThere appears to be a frequently repeated myth on social media that foreigners are selling…
> Read More🔎 At a Glance đź’¬ Ask a Question Have a question about the markets, your…
> Read MoreSeveral articles and social media posts have recently discussed the irregular partnerships that Nvidia is…
> Read MoreIn the “thematic models” we are rebalancing all models, and making changes to the AI, Growth Focused, Small-Mid Cap, Crypto and Accumulator models.
> Read MoreEli Lilly (LLY) and Novo Nordisk (NOVO) dominate the market for weight loss drugs. The…
> Read MoreMeme stocks are highly speculative stocks, heavily traded by retail traders, and characterized at times…
> Read MoreOur friend Jim Colquitt, in his Weekly Chart Review, brought to our attention a large…
> Read MoreDoes size matter? Since the Pandemic, and judged by the recent performance of the Magnificent…
> Read More🔎 At a Glance Fed Cuts Rates – Risk Management Or Mistake? Overbought Conditions Across…
> Read MoreSince the middle of July, UST 10-year yields have fallen from 4.50% to 4.00%. While…
> Read MoreNot surprisingly, the Fed cut rates by 25 basis points at yesterday’s meeting. With the…
> Read MorePresident Trump is pushing to reduce the SEC’s financial reporting requirements from quarterly to semiannual…
> Read MoreThe White House has turned its attention to the Bureau of Labor Statistics after a…
> Read MoreAfter years of abundant liquidity, U.S. overnight funding markets are beginning to show signs of…
> Read More🔎 At a Glance đź’¬ Ask a Question Have a question about the markets, your…
> Read More🔎 At a Glance đź’¬ Ask a Question Have a question about the markets, your…
> Read MoreOilfield service companies are fighting an uphill battle after years of weak demand from traditional…
> Read MoreThe AI infrastructure trade stagnated through August, with enthusiasm fading even after NVDA beat earnings…
> Read More